Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Chim Acta. 2013 Sep 23;424:19-21. doi: 10.1016/j.cca.2013.05.007. Epub 2013 May 13.

Liver cirrhosis treated by living donor liver transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA.

Author information

1
Okinaka Memorial Institute for Medical Research, Tokyo, Japan.

Abstract

Glycogen storage disease type III (GSD III) is an inherited disorder characterized by the accumulation of abnormal glycogen in the liver. Hepatic manifestations were considered as improving with age; however, patients live longer and liver cirrhosis is being recognized. We report a patient of GSD IIIa with liver cirrhosis, which was treated successfully by living donor liver transplantation. The patient proved to be a compound heterozygote for a novel small deletion c.2607-2610delATTC and a known duplication c.1672dupA in AGL, a gene coding glycogen debranching enzyme responsible for GSD III. Molecular diagnosis helped clinical decision-making.

KEYWORDS:

AGL; Glycogen storage disease type III; Liver cirrhosis; Living donor liver transplantation; Mutation

PMID:
23688858
DOI:
10.1016/j.cca.2013.05.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center